✦ LIBER ✦

A 6Fe ferredoxin from mycobacterium smegmatis

✍ Scribed by T. Imai; Y. Sakamoto; H. Saito; A. Urushiyama; K. Ohta; J. Tobari; D. Ohmori

Book ID: 103568423
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 71 KB
Volume: 43
Category: Article
ISSN: 0162-0134
DOI: 10.1016/0162-0134(91)84243-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A novel trehalase from Mycobacterium sme

A novel trehalase from Mycobacterium smegmatis − purification, properties, requirements

✍ J. David Carroll; Irena Pastuszak; Vineetha K. Edavana; Yuan T. Pan; Alan D. Elb 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 768 KB

Isolation and structural determination o

Isolation and structural determination of a “cord-factor” (trehalose 6,6′ dimycolate) from Mycobacterium smegmatis

✍ B. Mompon; C. Federici; R. Toubiana; E. Lederer 📂 Article 📅 1978 🏛 Elsevier Science 🌐 English ⚖ 363 KB

A rapid procedure for the isolation of s

A rapid procedure for the isolation of spheroplasts from Mycobacterium smegmatis

✍ Chanchal Sadhu; K.P. Gopinathan 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB

Organization of the origins of replicati

Organization of the origins of replication of the chromosomes of Mycobacterium smegmatis, Mycobacterium leprae and Mycobacterium tuberculosis and isolation of a functional origin from M. smegmatis

✍ Leirla Salazar; Hafida Fsihi; Edda de Rossi; Giovanna Riccardi; Carmen Rios; Ste 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 1024 KB

Ca2+/calmodulin dependent protein kinase

Ca2+/calmodulin dependent protein kinase from Mycobacterium smegmatis ATCC 607

✍ Sadhna Sharma; Shailendra Giri; G.K. Khuller 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 354 KB

Cytokine-modified Mycobacterium smegmati

Cytokine-modified Mycobacterium smegmatis as a novel anticancer immunotherapy

✍ Sarah L. Young; Michael Murphy; Xing Wu Zhu; Patricia Harnden; Michael A. O'Donn 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 253 KB

## Abstract Intravesical administration of live __M. bovis__ BCG organisms for carcinoma __in situ__ of the urinary bladder is the most successful immunotherapy for solid malignancy. Nevertheless BCG‐therapy is associated with significant toxicity and is ineffective in 30–40% of cases. Recently it